1)Nimura Y, Nagino M, Takao S, et al:Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas:long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19:230-241, 2012
2)Jang JY, Kang MJ, Heo JS, et al:A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg 259:656-664, 2014
3)Nagakawa Y, Hosokawa Y, Osakabe H, et al:Pancreaticoduodenectomy with right-oblique posterior dissection of superior mesenteric nerve plexus is logical procedure for pancreatic cancer with extrapancreatic nerve plexus invasion. Hepatogastroenterology 61:2371-2376, 2014
4)Toomey P, Hernandez J, Morton C, et al:Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg:75:804-809;discussion 9-10, 2009
5)Nakao A, Kanzaki A, Fujii T, et al:Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg 255:103-108, 2012
6)Motoi F, Kosuge T, Ueno H, et al:Randomized phase Ⅱ/Ⅲ trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer(Prep-02/JSAP05). Jpn J Clin Oncol 49:190-194, 2019
7)Valle JW, Palmer D, Jackson R, et al:Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas:ongoing lessons from the ESPAC-3 study. J Clin Oncol 32:504-512, 2014
8)Yabusaki N, Fujii T, Yamada S, et al:The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the analysis of clinicopathological factors influencing relative dose intensity. Medicine(Baltimore)95:e4282, 2016
9)日本膵臓学会(編):膵癌取扱い規約第6版.金原出版,2009
10)永川裕一,細川勇一,佐原八束,他:【膵悪性腫瘍に対する手術;エビデンス,術式と適応,手術手技のエッセンス】適切な神経叢郭清を併施する膵頭部癌根治術.消化器外科38:15-24,2015
11)永川裕一,易 勤,細川勇一,他:【手術に必要な外科解剖学】膵頭部癌手術に必要な外科解剖.消化器外科39:1059-1070,2016
12)Yoshioka H, Wakabayashi T:Therapeutic neurotomy on head of pancreas for relief of pain due to chronic pancreatitis;a new technical procedure and its results. AMA Arch Surg 76:546-554, 1958
13)日本膵臓学会(編):膵癌取扱い規約第3版,金原出版,1986
14)日本膵臓学会(編):膵癌取扱い規約第7版,金原出版,2016
15)永川裕一,易 勤,細川勇一,他:【Mesopancreasを攻める】膵頭神経叢の解剖.胆と膵38:41-48,2017
16)Nagakawa Y, Yi SQ, Takishita C, et al:Precise anatomical resection based on structures of nerve and fibrous tissue around the superior mesenteric artery for mesopancreas dissection in pancreaticoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci 27:342-351, 2020
17)上野桂一,永川宅和,太田哲生,他:膵頭部領域癌に対する拡大郭清膵切除術の評価 郭清度別にみた根治性と術後quality of life.日本消化器外科学会雑誌25:2666-2670,1992
18)土方陽介,永川裕一,粕谷和彦,他:膵頭部癌における上腸間膜動脈神経叢郭清の術後補助化学療法への影響.胆膵の病態生理.29:7-10,2013